DexCom (DXCM)
(Delayed Data from NSDQ)
$130.10 USD
+0.45 (0.35%)
Updated May 7, 2024 04:00 PM ET
After-Market: $130.07 -0.03 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Company Summary
San Diego, CA-based DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients.
A key element of DexCom’s monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company’s monitoring systems aim to provide real-time continuous blood glucose values, trend data ...
Company Summary
San Diego, CA-based DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients.
A key element of DexCom’s monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company’s monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Going by an article of Research and Markets, the blood glucose monitoring devices market is expected to witness a CAGR of over 9% between 2018 and 2024.
DexCom has collaborative agreements with several companies, which should not only bring in cash in the form of milestone payments and royalties but should also help expand its product use. It is also focusing on international markets
However, market for blood glucose monitoring devices is highly competitive, subject to rapid change and significantly affected by new product introductions.
2023 at a Glance
For the full-year 2023, the company reported adjusted EPS of $1.52, up 74.7% from 2022. Full-year 2023 revenues came in at $3.62 billion, up 24% year over year.
Revenues in the United States were up 23%. International revenues were up 30% reportedly as well as organically.
General Information
DexCom, Inc
6340 SEQUENCE DRIVE
SAN DIEGO, CA 92121
Phone: 858-200-0200
Fax: 858-200-0201
Email: investor-relations@dexcom.com
Industry | Medical - Instruments |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 3/31/2024 |
Exp Earnings Date | 7/25/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.39 |
Current Year EPS Consensus Estimate | 1.78 |
Estimated Long-Term EPS Growth Rate | 33.00 |
Exp Earnings Date | 7/25/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 129.65 |
52 Week High | 141.99 |
52 Week Low | 74.75 |
Beta | 1.23 |
20 Day Moving Average | 2,940,138.00 |
Target Price Consensus | 149.05 |
4 Week | -7.35 |
12 Week | 9.48 |
YTD | 4.48 |
4 Week | -6.97 |
12 Week | 6.13 |
YTD | -3.81 |
Shares Outstanding (millions) | 397.68 |
Market Capitalization (millions) | 51,559.71 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 73.00 |
Trailing 12 Months | 78.10 |
PEG Ratio | 2.21 |
vs. Previous Year | 88.24% |
vs. Previous Quarter | -36.00% |
vs. Previous Year | 24.21% |
vs. Previous Quarter | -10.97% |
Price/Book | 22.95 |
Price/Cash Flow | 62.66 |
Price / Sales | 13.56 |
3/31/24 | 31.01 |
12/31/23 | 28.31 |
9/30/23 | 25.05 |
3/31/24 | 10.29 |
12/31/23 | 9.74 |
9/30/23 | 8.99 |
3/31/24 | 2.90 |
12/31/23 | 2.84 |
9/30/23 | 2.80 |
3/31/24 | 2.53 |
12/31/23 | 2.48 |
9/30/23 | 2.50 |
3/31/24 | 17.71 |
12/31/23 | 16.94 |
9/30/23 | 16.07 |
3/31/24 | 16.82 |
12/31/23 | 14.95 |
9/30/23 | 11.08 |
3/31/24 | 20.48 |
12/31/23 | 19.61 |
9/30/23 | 17.56 |
3/31/24 | 5.65 |
12/31/23 | 5.35 |
9/30/23 | 5.87 |
3/31/24 | 2.73 |
12/31/23 | 2.89 |
9/30/23 | 3.09 |
3/31/24 | 1.08 |
12/31/23 | 1.18 |
9/30/23 | 1.07 |
3/31/24 | 52.02 |
12/31/23 | 54.06 |
9/30/23 | 51.75 |